AEG Deep Coverage Review — Analysis as of August 17, 2026
Central thesis. Aegon combines an inexpensive headline multiple, an active repurchase and a credible US-relocation narrative with a constructive market structure. The unresolved issue is evidence quality: the available package lacks the insurer-specific capital generation and solvency measures needed to determine whether the apparent discount is durable. The August 20 results are therefore the decisive near-term checkpoint.